Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer

Gwen M.H.E. Dackus, Katarzyna Jóźwiak, Elsken van der Wall, Paul J. van Diest, Michael Hauptmann, Sabine Siesling, Gabe S. Sonke, Sabine C. Linn*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
42 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science